UBS Group’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.2M | Buy |
361,264
+46,935
| +15% | +$155K | ﹤0.01% | 4213 |
|
|
2025
Q1 | $912K | Sell |
314,329
-106,234
| -25% | -$308K | ﹤0.01% | 4258 |
|
|
2024
Q4 | $1.5M | Buy |
420,563
+329,874
| +364% | +$1.17M | ﹤0.01% | 3934 |
|
|
2024
Q3 | $452K | Buy |
90,689
+63,651
| +235% | +$317K | ﹤0.01% | 4166 |
|
|
2024
Q2 | $70.3K | Buy |
27,038
+25,038
| +1,252% | +$65.1K | ﹤0.01% | 5284 |
|
|
2024
Q1 | $8.52K | Sell |
2,000
-290
| -13% | -$1.24K | ﹤0.01% | 6155 |
|
|
2023
Q4 | $4.63K | Buy |
+2,290
| New | +$4.63K | ﹤0.01% | 6632 |
|
|
2023
Q2 | – | Sell |
-3,744
| Closed | -$4.27K | – | 7775 |
|
|
2023
Q1 | $4.27K | Buy |
+3,744
| New | +$4.27K | ﹤0.01% | 7111 |
|
|
2022
Q4 | – | Sell |
-9,068
| Closed | -$11K | – | 9487 |
|
|
2022
Q3 | $11K | Buy |
9,068
+8,653
| +2,085% | +$10.5K | ﹤0.01% | 7170 |
|
|
2022
Q2 | $0 | Sell |
415
-414
| -50% | – | ﹤0.01% | 9217 |
|
|
2022
Q1 | $2K | Sell |
829
-1,130
| -58% | -$2.73K | ﹤0.01% | 8543 |
|
|
2021
Q4 | $8K | Sell |
1,959
-8,041
| -80% | -$32.8K | ﹤0.01% | 7889 |
|
|
2021
Q3 | $44K | Sell |
10,000
-4,060
| -29% | -$17.9K | ﹤0.01% | 5327 |
|
|
2021
Q2 | $56K | Sell |
14,060
-114
| -0.8% | -$454 | ﹤0.01% | 5267 |
|
|
2021
Q1 | $74K | Sell |
14,174
-9,595
| -40% | -$50.1K | ﹤0.01% | 5197 |
|
|
2020
Q4 | $128K | Buy |
23,769
+9,669
| +69% | +$52.1K | ﹤0.01% | 4548 |
|
|
2020
Q3 | $68K | Sell |
14,100
-23,981
| -63% | -$116K | ﹤0.01% | 4587 |
|
|
2020
Q2 | $185K | Buy |
38,081
+18,893
| +98% | +$91.8K | ﹤0.01% | 4058 |
|
|
2020
Q1 | $42K | Buy |
19,188
+9,188
| +92% | +$20.1K | ﹤0.01% | 5075 |
|
|
2019
Q4 | $58K | Hold |
10,000
| – | – | ﹤0.01% | 5218 |
|
|
2019
Q3 | $32K | Hold |
10,000
| – | – | ﹤0.01% | 5489 |
|
|
2019
Q2 | $42K | Sell |
10,000
-3,322
| -25% | -$14K | ﹤0.01% | 5201 |
|
|
2019
Q1 | $92K | Buy |
+13,322
| New | +$92K | ﹤0.01% | 4340 |
|
|
2018
Q4 | – | Sell |
-1,325
| Closed | -$23K | – | 7058 |
|
|
2018
Q3 | $23K | Buy |
+1,325
| New | +$23K | ﹤0.01% | 5803 |
|